Update on the molecular biology of malig
β
Amie Y. Lee; Dan J. Raz; Biao He; David M. Jablons
π
Article
π
2007
π
John Wiley and Sons
π
English
β 166 KB
## Abstract Malignant mesothelioma (MM) is a highly aggressive tumor with a very poor prognosis. The disease is largely unresponsive to conventional chemotherapy or radiotherapy, and most patients die within 10β17 months of the first symptoms. Novel, more effective therapeutic strategies are needed